|
|
|
A BILL TO BE ENTITLED
|
|
AN ACT
|
|
relating to the licensing and regulation of pharmacists and |
|
pharmacies. |
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
SECTION 1. Section 481.075(i), Health and Safety Code, is |
|
amended to read as follows: |
|
(i) Each dispensing pharmacist shall: |
|
(1) fill in on the official prescription form or note |
|
in the electronic prescription record each item of information |
|
given orally to the dispensing pharmacy under Subsection (h) and |
|
the date the prescription is filled, and: |
|
(A) for a written prescription, fill in the |
|
dispensing pharmacist's signature; or |
|
(B) for an electronic prescription, |
|
appropriately record the identity of the dispensing pharmacist in |
|
the electronic prescription record; |
|
(2) retain with the records of the pharmacy for at |
|
least two years: |
|
(A) the official prescription form or the |
|
electronic prescription record, as applicable; and |
|
(B) the name or other patient identification |
|
required by Section 481.074(m) or (n); [and] |
|
(3) send all required information, including any |
|
information required to complete an official prescription form or |
|
electronic prescription record, to the board by electronic transfer |
|
or another form approved by the board not later than the next |
|
business day after the date the prescription is completely filled; |
|
and |
|
(4) if the pharmacy does not dispense any controlled |
|
substance prescriptions during a period of seven consecutive days, |
|
send a report to the board indicating that the pharmacy did not |
|
dispense any controlled substance prescriptions during that |
|
period, unless the pharmacy has obtained a waiver or permission to |
|
delay reporting to the board. |
|
SECTION 2. Sections 481.076(a) and (k), Health and Safety |
|
Code, are amended to read as follows: |
|
(a) The board may not permit any person to have access to |
|
information submitted to the board under Section 481.074(q) or |
|
481.075 except: |
|
(1) the board, the Texas Medical Board, the Texas |
|
Department of Licensing and Regulation, with respect to the |
|
regulation of podiatrists [State Board of Podiatric Medical
|
|
Examiners], the State Board of Dental Examiners, the State Board of |
|
Veterinary Medical Examiners, the Texas Board of Nursing, or the |
|
Texas Optometry Board for the purpose of: |
|
(A) investigating a specific license holder; or |
|
(B) monitoring for potentially harmful |
|
prescribing or dispensing patterns or practices under Section |
|
481.0762; |
|
(2) an authorized officer or member of the department |
|
or authorized employee of the board engaged in the administration, |
|
investigation, or enforcement of this chapter or another law |
|
governing illicit drugs in this state or another state; |
|
(3) the department on behalf of a law enforcement or |
|
prosecutorial official engaged in the administration, |
|
investigation, or enforcement of this chapter or another law |
|
governing illicit drugs in this state or another state; |
|
(4) a medical examiner conducting an investigation; |
|
(5) provided that accessing the information is |
|
authorized under the Health Insurance Portability and |
|
Accountability Act of 1996 (Pub. L. No. 104-191) and regulations |
|
adopted under that Act: |
|
(A) a pharmacist or a pharmacist-intern, |
|
pharmacy technician, or pharmacy technician trainee, as defined by |
|
Section 551.003, Occupations Code, acting at the direction of a |
|
pharmacist, who is inquiring about a recent Schedule II, III, IV, or |
|
V prescription history of a particular patient of the pharmacist; |
|
or |
|
(B) a practitioner who: |
|
(i) is a physician, dentist, veterinarian, |
|
podiatrist, optometrist, or advanced practice nurse or is a |
|
physician assistant described by Section 481.002(39)(D) or an |
|
employee or other agent of a practitioner acting at the direction of |
|
a practitioner; and |
|
(ii) is inquiring about a recent Schedule |
|
II, III, IV, or V prescription history of a particular patient of |
|
the practitioner; |
|
(6) a pharmacist or practitioner who is inquiring |
|
about the person's own dispensing or prescribing activity or a |
|
practitioner who is inquiring about the prescribing activity of an |
|
individual to whom the practitioner has delegated prescribing |
|
authority; or |
|
(7) one or more states or an association of states with |
|
which the board has an interoperability agreement, as provided by |
|
Subsection (j). |
|
(k) A person authorized to access information under |
|
Subsection (a)(4) or (5) who is registered with the board for |
|
electronic access to the information is entitled to directly access |
|
the information available from other states pursuant to an |
|
interoperability agreement described by Subsection (j). |
|
SECTION 3. Section 481.0766(a), Health and Safety Code, is |
|
amended to read as follows: |
|
(a) A wholesale distributor shall report to the board the |
|
distribution of all Schedules II, III, IV, and V controlled |
|
substances [information that the distributor is required to report
|
|
to the Automation of Reports and Consolidated Orders System (ARCOS)
|
|
of the Federal Drug Enforcement Administration for the distribution
|
|
of a controlled substance] by the distributor to a person in this |
|
state. The distributor shall report the information to the board in |
|
the same format and with the same frequency as the information is |
|
reported to the Federal Drug Enforcement Administration [ARCOS]. |
|
SECTION 4. Section 481.353(a), Health and Safety Code, is |
|
amended to read as follows: |
|
(a) The work group shall meet when necessary as determined |
|
by the board [at least quarterly]. |
|
SECTION 5. Section 560.051(f), Occupations Code, is amended |
|
to read as follows: |
|
(f) A Class E pharmacy license or nonresident pharmacy |
|
license may be issued to a pharmacy located in another state whose |
|
primary business is to: |
|
(1) [(A)] dispense a prescription drug or device under |
|
a prescription drug order[;] and |
|
[(B)] deliver the drug or device to a patient, |
|
including a patient in this state, by United States mail, common |
|
carrier, or delivery service; |
|
(2) process a prescription drug order for a patient, |
|
including a patient in this state; or |
|
(3) perform another pharmaceutical service, as |
|
defined by board rule. |
|
SECTION 6. The following provisions of the Occupations Code |
|
are repealed: |
|
(1) Sections 554.016, 556.0555, 560.001(c), 560.0525, |
|
561.003(f), 562.101(f-1), and 562.111; and |
|
(2) Subchapter E, Chapter 562. |
|
SECTION 7. This Act takes effect September 1, 2019. |